Why Fortescue’s Sell Rating Persists Even After a 27% Price Fall
Key Takeaways
- RaaS Group analyst Joshua Baker issued an FMG sell rating in the week of 14 September 2026, arguing Fortescue shares at A$16.63 remain overpriced even after a 27.5% fall from the A$22.99 twelve-month high.
- FY2026 revenue grew 9% to US$16.97 billion, but statutory profit fell 15% to US$2.86 billion after a US$750 million pre-tax Iron Bridge impairment and a US$73 million compensation charge.
- Fortescue cut its final dividend 23% from 60 cents to 46 cents per share, a directional signal that capital return headroom is already under pressure despite a trailing yield of around 6.5%.
- Iron Bridge's 22 Mt/year nameplate capacity target was withdrawn entirely in August 2026, attributable production was cut roughly 22%, and Q4 FY2026 unit cash costs jumped around 19% quarter-on-quarter, compounding a multi-year pattern of guidance resets.
- The Australian Government's DISR forecasts iron ore prices declining to around US$64/t real by 2031, which would sharply compress Fortescue's margins against its revised hematite unit cash cost of roughly US$21/t, and BHP's competing US$80/t structural floor argument is the key variable separating the value-opportunity and structural-de-rating theses.
Fortescue’s revenue grew 9% in FY2026 to US$16.97 billion, yet its statutory profit fell 15% and its final dividend was slashed by 23%. That combination does not fit the tidy story of a mining major firing on all cylinders.
That paradox is why the debate over Fortescue right now is worth your attention. In the week of 14 September 2026, RaaS Group analyst Joshua Baker put a sell rating on the stock. The shares have fallen from A$22.99 on 14 May 2026 to around A$16.63 today, a 27.5% slide from the 12-month high.
So you are left with a genuine question, not a rhetorical one: is a 6.5%-yielding iron ore major trading a quarter below its peak a discounted entry point, or a business in the early stages of a structural de-rating?
This piece gives you the evidence to answer that from four angles: the logic behind the sell rating, the quality of the FY2026 result beneath the impairment noise, the Iron Bridge problem, and where iron ore prices are actually heading. It closes with a framework for making the call rather than a verdict handed to you.
Why RaaS Group is telling investors to sell Fortescue now
Joshua Baker’s sell rating is not a panic call. It is a structured argument, and understanding its shape matters more than the one-word conclusion attached to it.
Published via The Bull during the week of 14 September 2026, Baker’s case rests on four pillars:
- Declining statutory profits in the FY2026 result
- A dividend cut that signals thinning headroom for capital returns
- Rising capital expenditure guidance for FY2027 against FY2026 levels
- An iron ore price outlook he views as unattractive relative to other commodity exposures
That last pillar is the one doing the heavy lifting. Baker is not arguing Fortescue is heading for insolvency or operational collapse. He is arguing that iron ore, as an exposure, looks weaker than commodities tied to electrification and decarbonisation.
The core of the bear case is comparative, not absolute: the iron ore outlook is assessed as unattractive relative to competing commodity exposures, not as a business in distress.
This distinction changes how you should read the recommendation. A relative call weakens the moment the comparison shifts, whether through iron ore price stabilisation or through Fortescue proving it can hold its cost line.
The timing is the telling part. Baker issued the sell rating with the shares already down roughly 12.1% over 12 months to the A$16.63 level, and 27.5% below the A$22.99 high. He is not calling a peak. He is arguing that even after that fall, and even with a trailing yield near 6.5%, the stock is not yet cheap enough to compensate for the structural risks ahead.
What his call tells you is uncomfortable but clarifying. A 6.5% yield and a 27% price decline have not, in Baker’s view, made Fortescue cheap. For the bear case to weaken, the market needs to see one of two things: iron ore prices finding a durable floor, or Iron Bridge demonstrating cost discipline. Neither has arrived yet.
Baker’s sell rating is one data point in a broader pattern: fair value cuts linked to production woes at Iron Bridge have come from multiple analyst desks in the months following the FY2026 result, each applying different discount rates to the magnetite asset’s forward cash flows.
When big ASX news breaks, our subscribers know first
What the FY2026 results actually show beneath the headline numbers
Read the headline and Fortescue looks like it stumbled. Read the detail and the picture is more divided: a growing top line, a genuinely profitable core, and a large charge that muddies the whole result.
Revenue rose 9% to US$16.97 billion, reported on 20 August 2026. That is real growth, driven by the core hematite operations that ship roughly 190-200 Mt of ore a year. On its own, it points to a business that is still selling well.
The statutory net profit after tax told a harsher story at US$2.86 billion, down 15% year-on-year. The gap between rising revenue and falling profit is where the analysis lives.
Two charges explain much of it. Fortescue booked a non-cash impairment of US$525 million after tax (US$750 million pre-tax) against Iron Bridge, plus an additional US$73 million compensation claim expense.
The single most striking number in the result is the total Iron Bridge write-down: approximately A$1.1 billion.
Strip those charges out and you get a cleaner read on the core business, and that read is the one that matters for the dividend. The hematite operations remain cash-generative. The impairment is non-cash and partly one-off. If you fixate on the 15% statutory drop alone, you misread the result.
But you can misread it in the other direction too. The impairment reveals a cost and capex trajectory that is not one-off at all. Hematite unit cash costs were revised up around 1% to roughly US$21/t, and FY2027 cost guidance sits above prior consensus. That is ongoing pressure, not an accounting artefact.
The dividend is where the two readings collide. The final payout was cut to 46 cents per share from 60 cents, a 23% reduction. The full 12-month distribution of $1.08 per share still yields around 6.5%.
| Metric | FY2025 | FY2026 | Change |
|---|---|---|---|
| Revenue | US$15.57B (approx) | US$16.97B | +9% |
| Statutory NPAT | US$3.36B (approx) | US$2.86B | -15% |
| Final dividend per share | 60 cents | 46 cents | -23% |
| Total 12-month dividend per share | Higher base | $1.08 | Lower |
The yield still looks attractive in isolation. The direction of travel, from 60 cents to 46 cents, is what should concern you more, because it signals the pressure on capital returns has already started to bite.
Iron Bridge: execution problem or structural flaw?
Iron Bridge is where the whole thesis is decided. Before assessing its problems, you need to know what it is.
Iron Bridge is Fortescue’s 69%-owned magnetite project. Magnetite is a lower-grade iron ore that requires more processing than the direct-shipping hematite that dominates Fortescue’s output, but it produces a high-grade concentrate. The project aims to become the first magnetite operation running on renewable energy by 2030, a centrepiece of Fortescue’s green strategy.
The operational data is mixed. FY2026 shipments reached 9.0 Mt, up from 7.1 Mt the prior year. That is growth. But it is a long way below the original 22 Mt/year nameplate ambition, and Q4 FY2026 shipments fell around 5% year-on-year while unit cash costs jumped roughly 19% quarter-on-quarter.
The track record is where the bear case sharpens. Iron Bridge has a multi-year history of guidance resets:
- Prior to FY2026, the nameplate capacity timeline was already pushed out to FY2028 with shipment targets revised more than once (coverage from May 2025)
- In the FY2026 result on 20 August 2026, Fortescue withdrew the 22 Mt/year capacity target entirely
- The attributable production forecast was cut around 22% to roughly 8.6 Mt
- A US$750 million pre-tax impairment (approximately A$1.1 billion) was booked against the project
Development costs reportedly ran close to US$4 billion over the project’s life. The AFR has described Iron Bridge as “trouble-prone.” On top of that, changes to China’s iron ore procurement through CMRG (China Mineral Resources Group) have stalled pricing negotiations with Chinese buyers, adding commercial risk to a project that is already behind plan.
The Iron Bridge impairment charge has attracted close scrutiny from investors trying to separate a one-off accounting event from evidence of a recurring cost problem, and the distinction carries significant weight for anyone building a position at current prices.
What this pattern tells you is straightforward. A multi-year run of resets means you cannot value Iron Bridge on management’s stated targets. You need to apply a discount for execution credibility before building any of it into a thesis.
The case for a reset rather than a failure
The contrarian read deserves a fair hearing, because the bulls are not making things up.
The write-down does one useful thing: it resets the valuation base to a more achievable level. If future expectations are lower, the risk of another impairment falls rather than rises. A conservative baseline can be easier to beat.
Shipments of 9.0 Mt versus 7.1 Mt show the project is operationally alive, not stranded. It is scaling slowly, but it is scaling.
Most importantly, Iron Bridge does not define the whole company. Fortescue’s core hematite operations, at roughly 190-200 Mt a year, remain highly cash-generative at current iron ore prices. Full-year FY2026 shipments across the group were up around 1% despite the Q4 pressure. Iron Bridge is the disputed asset; it is not the business.
That is why this is a genuine dispute rather than a settled question. Whether Iron Bridge is a fixable execution problem or a deeper strategic miscalculation is the single most important variable in deciding if A$16.63 is a floor or a midpoint in a longer decline.
Where iron ore prices are headed, and what that means for the bear case
Baker’s sell case ultimately rests on the iron ore price. The evidence there does not point cleanly in one direction, and that ambiguity is the whole story.
Start with the near term. The 62% Fe benchmark has traded in a US$93-100/t band since June 2026, with a reading of US$98.02/t on 11 September 2026. Epignosis Insights, tracking the China market, judged as of 1 September 2026 that prices had “likely found a near-term floor,” having eased only modestly from US$99.20/t to US$95.84/t over six weeks.
BHP makes the structural floor argument. In its 18 August 2026 commodity outlook, BHP estimated that around 260 Mt of seaborne supply now requires prices above US$80/t CFR to stay economic, up from roughly 180 Mt in 2025.
BHP’s read is that sustaining prices materially below US$80/t CFR would require weaker steel demand and faster low-cost supply growth at the same time, a combination it considers difficult to hold.
The long-term view from the Australian Government complicates that. The Department of Industry, Science and Resources (DISR), in its June 2026 quarterly updated on 13 August 2026, forecasts the benchmark to average US$91/t in 2026 before declining to around US$64/t in real terms by 2031, on moderating steel demand and expanding supply.
| Source | Near-term view | Long-term view | Key assumption |
|---|---|---|---|
| DISR | Avg US$91/t in 2026 | ~US$64/t real by 2031 | Softer steel demand, more supply |
| BHP | Cost-supported entering 2026 | Structural floor ~US$80/t CFR | 260 Mt needs above US$80/t to stay economic |
| Epignosis | Likely found a near-term floor | Stabilisation in mid-US$90s/t | Modest recent price easing |
The divergence is the point. If you weight BHP’s floor argument, the downside is limited and the bear case softens. If you weight DISR’s long-run decline, the macro backdrop is deteriorating and Baker’s comparative case gains force.
China’s demand and supply constraints are doing more work in the iron ore price equation than any single producer’s output decision, with CMRG procurement changes and steel mill utilisation rates creating the demand-side uncertainty that underpins both the DISR forecast decline and BHP’s cost-floor argument.
What the price range means for Fortescue’s cost margins
Turn the prices into margins and the tension becomes concrete.
Against Fortescue’s revised hematite unit cash cost of roughly US$21/t, current spot around US$98/t leaves a wide margin. That is why the core business remains cash-generative today.
Now apply DISR’s 2031 projection of around US$64/t real. The margin over a US$21/t cost base narrows sharply, and that is before any upward drift in costs, which FY2027 guidance already implies.
Iron Bridge adds a further layer. Magnetite processing costs sit above the headline hematite figure, so the composite cost picture is less favourable than the US$21/t number alone suggests. If DISR’s trajectory is even directionally right, the gap between Fortescue’s costs and the iron ore price compresses over time. That compression is precisely what Baker’s “unattractive relative to competing commodities” framing is pricing in.
The next major ASX story will hit our subscribers first
Value opportunity or structural de-rating: how to frame the decision
You now have the evidence. The remaining task is turning it into a decision framework rather than waiting for a consensus that may never form.
Two theses compete. The value-opportunity case holds that the core hematite business is profitable, the impairment resets Iron Bridge to an achievable base, the shares have already de-rated 27.5%, and BHP’s cost floor limits further commodity downside. The structural-de-rating case holds that rising unit costs, lifted capex, Iron Bridge execution risk, DISR’s long-run price decline, and a pattern of guidance misses point to sustained pressure on earnings and dividends.
A useful way to test which is prevailing is the value-trap versus value-opportunity framework that has separated recoveries from traps in past mining cycles.
| Framework dimension | Value opportunity reading | Structural de-rating reading |
|---|---|---|
| Balance sheet | Core hematite cash flow supports resilience | Capex lift constrains free cash flow |
| Capex quality/timing | Impairment resets to conservative base | Magnetite spend still high-intensity, uncertain returns |
| Dividend coverage | 6.5% yield still funded by hematite | Cut from 60c to 46c signals thinning headroom |
| Management credibility | Reset may mark a more realistic stance | Multi-year Iron Bridge misses erode trust |
Applied to Fortescue, the picture leans toward the execution-risk end on capex quality and management credibility, and toward resilience on the balance sheet and current dividend coverage.
For investors wanting to stress-test the value-opportunity versus structural-de-rating framework across a broader set of cases, our full explainer on value traps in the Australian mining sector examines how dividend yield, cost trajectory, and commodity cycle positioning have separated recoveries from prolonged de-ratings in past ASX mining cycles.
To judge which thesis is winning over the next six to twelve months, watch these specific, observable variables:
- Iron Bridge quarterly cost trajectory, starting with the Q1 FY2027 report
- The 62% Fe price relative to BHP’s US$80/t floor
- FY2027 capex guidance at the next update
- Any further change to dividend guidance from the 46 cents base
At A$16.63 with a 6.5% trailing yield, Fortescue is priced for concern but not for catastrophe. The question that decides your call is whether Iron Bridge stabilisation and the iron ore cost floor are credible enough to prevent a further leg down as FY2027 cost guidance lands.
This article is for informational purposes only and should not be considered financial advice. Investors should conduct their own research and consult with financial professionals before making investment decisions. Past performance does not guarantee future results. Financial projections are subject to market conditions and various risk factors.
What to watch before making a call on Fortescue in FY2027
The bear case is credible, but it is not settled. Several near-term data points could tip the balance either way before the end of calendar 2026, and knowing what they are is more useful than any snapshot verdict today.
Here is the checklist, in priority order:
- Iron Bridge’s Q1 FY2027 production and cost report, measured against the roughly 19% quarter-on-quarter unit cost rise in Q4 FY2026. This is the first read on whether the August reset is stabilising.
- Any update to FY2027 capex guidance, which currently sits lifted across the forecast period and constrains free cash flow.
- The 62% Fe spot price relative to BHP’s US$80/t structural floor, against DISR’s US$91/t average forecast for 2026.
- Further Fortescue commentary on the CMRG procurement situation and stalled Chinese buyer pricing.
The most important of these is the Iron Bridge cost trajectory. If Q1 FY2027 shows any quarter-on-quarter stabilisation, the structural de-rating narrative weakens. If costs worsen, Baker’s sell case hardens and the stock has further to fall than A$16.63 implies.
This setup suits investors with a higher risk tolerance who believe in the hematite cost floor and the Iron Bridge stabilisation narrative. Investors who require guidance credibility and dividend predictability before buying are still waiting for evidence that, at present, does not yet exist.
The 46 cents final dividend is now the baseline for judging future payouts. Watch whether it holds. That single figure, more than any analyst rating, will tell you which thesis the numbers are supporting.
Frequently Asked Questions
What is the RaaS Group FMG sell rating based on?
Analyst Joshua Baker's sell rating, published in the week of 14 September 2026, rests on four pillars: declining statutory profits in the FY2026 result, a 23% dividend cut, rising FY2027 capex guidance, and an iron ore price outlook he considers unattractive relative to commodities tied to electrification and decarbonisation.
Why did Fortescue cut its final dividend in FY2026?
Fortescue reduced its final dividend from 60 cents to 46 cents per share, a 23% cut, as statutory net profit fell 15% to US$2.86 billion, partly driven by a US$750 million pre-tax impairment against Iron Bridge and rising unit costs at the hematite operations.
What is Iron Bridge and why is it a problem for Fortescue?
Iron Bridge is Fortescue's 69%-owned magnetite project targeting high-grade concentrate production, but it has a multi-year history of guidance resets: the company withdrew its 22 Mt/year nameplate capacity target entirely in August 2026, cut attributable production forecasts by around 22%, and booked approximately A$1.1 billion in impairment charges against the asset.
Where are iron ore prices forecast to go by 2031?
The Australian Government's Department of Industry, Science and Resources forecast the 62% Fe benchmark to average US$91/t in 2026 before declining to around US$64/t in real terms by 2031, driven by moderating steel demand and expanding seaborne supply, though BHP argues a structural cost floor near US$80/t CFR limits the downside.
What data points should investors watch to assess whether Fortescue is a value opportunity or a structural de-rating?
The most critical variable is Iron Bridge's Q1 FY2027 unit cost trajectory, which will confirm whether the August 2026 reset is stabilising or worsening; secondary signals include any FY2027 capex guidance update, the 62% Fe spot price relative to the US$80/t structural floor, and whether the 46 cents final dividend baseline holds.

